{"name":"TxCell","permalink":"txcell","crunchbase_url":"http://www.crunchbase.com/company/txcell","homepage_url":"http://www.txcell.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"contact@txcell.com","phone_number":"+33(0) 497 218 300","description":"","created_at":"Thu Mar 10 05:49:51 UTC 2011","updated_at":"Thu Dec 06 02:13:37 UTC 2012","overview":"<p>TxCell, a spin off of Inserm (France&#8217;s National Institute for Health and Medical\nResearch) located in the technology park of Sophia Antipolis, near Nice in\nsouthern France, is developing cell-based immuno-therapies for the treatment of\nsevere chronic inflammatory diseases with high medical need using its unique\nand proprietary technology platform based on the properties of Type 1 regulatory\nT lymphocytes (Tr1 cells). The company has completed enrollment of a PhI/II\nstudy in refractory Crohn&#8217;s disease patients and has reported first positive\nresults. The company plans to initiate a PhIIb study in the same patient\npopulation and bring a second product candidate into a PhI/II study in refractory\nrheumatoid arthritis patients.</p>","image":{"available_sizes":[[[150,65],"assets/images/resized/0012/5745/125745v1-max-150x150.png"],[[189,82],"assets/images/resized/0012/5745/125745v1-max-250x250.png"],[[189,82],"assets/images/resized/0012/5745/125745v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"CEO","person":{"first_name":"Francois","last_name":"Meyer","permalink":"franois-meyer","image":null}},{"is_past":false,"title":"CFO","person":{"first_name":"Christophe","last_name":"Sarlot","permalink":"christophe-sarlot","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"€12.4M","funding_rounds":[{"round_code":"c","source_url":"http://www.finsmes.com/2012/11/txcell-raises-e12-4m-financing.html","source_description":"TxCell Raises €12.4M in Third Financing","raised_amount":12400000,"raised_currency_code":"EUR","funded_year":2012,"funded_month":11,"funded_day":26,"investments":[{"company":null,"financial_org":{"name":"InnoBio Fund","permalink":"innobio-fund","image":null},"person":null},{"company":null,"financial_org":{"name":"Auriga Partners","permalink":"auriga-partners","image":{"available_sizes":[[[141,16],"assets/images/resized/0003/9844/39844v1-max-150x150.png"],[[141,16],"assets/images/resized/0003/9844/39844v1-max-250x250.png"],[[141,16],"assets/images/resized/0003/9844/39844v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Seventure Partners","permalink":"seventure-partners","image":{"available_sizes":[[[150,83],"assets/images/resized/0022/4088/224088v1-max-150x150.jpg"],[[250,139],"assets/images/resized/0022/4088/224088v1-max-250x250.jpg"],[[250,139],"assets/images/resized/0022/4088/224088v1-max-450x450.jpg"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"Les Cardoulines HT1","address2":"AllÃ©e de la NertiÃ¨re, ","zip_code":"06560 ","city":"Valbonne, Sophia-Antipolis","state_code":null,"country_code":"FRA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}